Blocking HGF in cancer-associated mesenchymal stem cells, where HGF is hyper-produced, may also be a potential GC treatment strategy based on a recent in vivo study.250 Currently, the precise regulatory cascades of HGF/c-MET in GC cells have not been fully elucidated. This evidence concerns the gene MET and cancer.